Care Health Insurance

₹134.00

0.00% 05 Mar 2026

Listing Status: Active

careinsurance.com

•••• ••••

•••

Key Metrics of Care Health Insurance

Market Cap 13054.07 Cr.
Total Equity Funding$80M in 2 rounds
Latest Funding Round$76M, Series B Jun 03, 2020
Post Money Valuation—
Annual Revenue—
EBITDA—
EBITDA Margin—
Net Profit—
Net Profit Margin—

About the Company

Provider of health and travel insurance plans. It offers various health insurance options, including individual, family, senior citizen, and specialized...

Price on BSE Volume

Funding Rounds

Total Rounds: 2 Careinsurance

S.No.	Date	Round Name	Amount	TTM Revenue	Investors & Facilitators
1.	Jun 3, 2020	Series B	$75.6M	-	Inst: Trishikar Ventures, Swarnim Multiventures, LKP, Kedaara
2.	Jun 28, 2019	Series A	$3.9M	-	Inst: Swarnim Multiventures, LKP, Gland Celsus Biochemicals

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25

FY 23-24

FY 22-23

FY 21-22

FY 20-21

FY 19-20

FY 18-19

FY 17-18

FY 16-17

FY 15-16

FY 14-15

FY 13-14

Detailed Income Statement

FY 24-25 (in Cr)

0.0

Total profit before prior period items, exceptional items, extraordinary items and tax

0.0

Total profit before extraordinary items and tax

0.0

Total profit before tax

0.0

Total profit (loss) for period from continuing operations

0.0

Total profit (loss) for period

0.0

Detailed Balance Sheet	FY 24-25 (in Cr)

Detailed Cash Flow Statement	FY 24-25 (in Cr)

Detailed Income Statement

FY 23-24 (in Cr)

142.9

356.0

88.8

For doubtful debts

Expenses other than those related to Insurance Business

4.4

Bad debts written off

0.6

Expenses towards CSR activities

2.8

Penalties

0.0

Towards Excess Expenses of Management

80.8

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

0.2

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

Profit/(Loss) before tax

410.1

105.2

Profit/(Loss) for the year

304.9

Detailed Balance Sheet

FY 23-24 (in Cr)

2,197.7

6,716.1

396.9

Current Liabilities

(2,002.6)

Provisions

(2,912.7)

Debit Balance In Profit And Loss Account

Other Net assets

Detailed Cash Flow Statement	FY 23-24 (in Cr)
Cash flow from Operating activities	1,048.5
Net cash from/(used in) Operating activities	1,048.5
Cash flow from Investing activities	(1,168.0)
Net cash from/(used in) Investing activities	(1,168.0)
Cash flow from Financing activities	115.8
Net cash from/(used) in Financing activities	115.8
Effect of exchange rate changes on cash and cash equivalents	(0.2)
Net increase /(Decrease) in cash and cash equivalents	(4.0)
Cash and cash equivalents at the beginning of the year	99.8
Cash and cash equivalents at the end of the year	95.8

Detailed Income Statement

FY 22-23 (in Cr)

105.1

643.7

420.8

For doubtful debts

Expenses other than those related to Insurance Business

6.0

Bad debts written off

1.4

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

(1.8)

Corporate Social Responsibilty (CSR) Expenses

1.0

Sandbox related expenses

0.0

Contribution to the Policyholders' Fund towards Excess EoM*

414.2

Others

Profit/(Loss) before tax

328.0

82.1

Profit/(Loss) for the year

245.9

Detailed Balance Sheet

FY 22-23 (in Cr)

1,743.5

5,179.3

337.1

Current Liabilities

(1,559.5)

Provisions

(2,213.4)

Debit Balance In Profit And Loss Account

Other Net assets

Detailed Cash Flow Statement	FY 22-23 (in Cr)
Cash flow from Operating activities	1,029.3
Net cash from/(used in) Operating activities	1,029.3
Cash flow from Investing activities	(1,305.7)
Net cash from/(used in) Investing activities	(1,305.7)
Cash flow from Financing activities	295.7
Net cash from/(used) in Financing activities	295.7
Effect of exchange rate changes on cash and cash equivalents	1.8
Net increase /(Decrease) in cash and cash equivalents	21.1
Cash and cash equivalents at the beginning of the year	78.7
Cash and cash equivalents at the end of the year	99.8

Detailed Income Statement

FY 21-22 (in Cr)

58.4

283.0

For doubtful debts

Expenses other than those related to Insurance Business

4.6

Bad debts written off

0.7

Expenses towards CSR activities

1.3

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

318.7

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(325.3)

Profit/(Loss) before tax

15.6

4.1

Profit/(Loss) for the year

11.5

Detailed Balance Sheet

FY 21-22 (in Cr)

1,288.7

3,661.1

236.2

Current Liabilities

(1,161.2)

Provisions

(1,529.2)

Debit Balance In Profit And Loss Account

81.8

Other Net assets

Detailed Cash Flow Statement	FY 21-22 (in Cr)
Cash flow from Operating activities	667.5
Net cash from/(used in) Operating activities	667.5
Cash flow from Investing activities	(787.2)
Net cash from/(used in) Investing activities	(787.2)
Cash flow from Financing activities	153.2
Net cash from/(used) in Financing activities	153.2
Effect of exchange rate changes on cash and cash equivalents	(0.5)
Net increase /(Decrease) in cash and cash equivalents	33.0
Cash and cash equivalents at the beginning of the year	45.7
Cash and cash equivalents at the end of the year	78.7

Detailed Income Statement

FY 20-21 (in Cr)

60.1

262.8

For doubtful debts

Expenses other than those related to Insurance Business

4.6

Bad debts written off

0.8

Expenses towards CSR activities

0.7

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

240.2

Corporate Social Responsibilty (CSR) Expenses

0.0

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(246.3)

Profit/(Loss) before tax

75.5

(26.7)

Profit/(Loss) for the year

102.2

Detailed Balance Sheet

FY 20-21 (in Cr)

1,130.5

2,726.2

191.1

Current Liabilities

(791.9)

Provisions

(1,088.2)

Debit Balance In Profit And Loss Account

93.3

Other Net assets

Detailed Cash Flow Statement	FY 20-21 (in Cr)
Cash flow from Operating activities	379.2
Net cash from/(used in) Operating activities	379.2
Cash flow from Investing activities	(725.7)
Net cash from/(used in) Investing activities	(725.7)
Cash flow from Financing activities	337.4
Net cash from/(used) in Financing activities	337.4
Effect of exchange rate changes on cash and cash equivalents	(1.0)
Net increase /(Decrease) in cash and cash equivalents	(10.2)
Cash and cash equivalents at the beginning of the year	55.9
Cash and cash equivalents at the end of the year	45.7

Detailed Income Statement

FY 19-20 (in Cr)

22.8

256.2

For doubtful debts

Expenses other than those related to Insurance Business

5.6

Bad debts written off

0.6

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

0.3

Sandbox related expenses

0.0

Contribution to the Policyholders' Fund towards Excess EoM*

205.9

Others

(212.5)

Profit/(Loss) before tax

65.9

0.2

Profit/(Loss) for the year

65.7

Detailed Balance Sheet

FY 19-20 (in Cr)

781.0

1,830.2

170.0

Current Liabilities

(681.2)

Provisions

(733.6)

Debit Balance In Profit And Loss Account

195.6

Other Net assets

Detailed Cash Flow Statement	FY 19-20 (in Cr)
Cash flow from Operating activities	0
Net cash from/(used in) Operating activities	0
Cash flow from Investing activities	0
Net cash from/(used in) Investing activities	0
Cash flow from Financing activities	0
Net cash from/(used) in Financing activities	0
Effect of exchange rate changes on cash and cash equivalents	0
Net increase /(Decrease) in cash and cash equivalents	0
Cash and cash equivalents at the beginning of the year	0
Cash and cash equivalents at the end of the year	0

Detailed Income Statement

FY 18-19 (in Cr)

21.3

241.3

9.8

For doubtful debts

9.8

Expenses other than those related to Insurance Business

16.9

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

9.8

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

179.5

Others

(206.2)

Profit/(Loss) before tax

56.9

Profit/(Loss) for the year

56.9

Detailed Balance Sheet

FY 18-19 (in Cr)

700.9

1,358.1

213.7

Current Liabilities

(544.1)

Provisions

(588.0)

Debit Balance In Profit And Loss Account

261.2

Other Net assets

Detailed Cash Flow Statement	FY 18-19 (in Cr)
Cash flow from Operating activities	242.6
Net cash from/(used in) Operating activities	242.6
Cash flow from Investing activities	(321.1)
Net cash from/(used in) Investing activities	(321.1)
Cash flow from Financing activities	93.7
Net cash from/(used) in Financing activities	93.7
Effect of exchange rate changes on cash and cash equivalents	0.5
Net increase /(Decrease) in cash and cash equivalents	15.6
Cash and cash equivalents at the beginning of the year	24.6
Cash and cash equivalents at the end of the year	40.2

Detailed Income Statement

FY 17-18 (in Cr)

3.8

(28.5)

For doubtful debts

Expenses other than those related to Insurance Business

3.9

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(3.9)

Profit/(Loss) before tax

(16.3)

Profit/(Loss) for the year

(16.3)

Detailed Balance Sheet

FY 17-18 (in Cr)

594.2

973.8

125.5

Current Liabilities

(420.8)

Provisions

(402.5)

Debit Balance In Profit And Loss Account

318.1

Other Net assets

0.0

Detailed Cash Flow Statement	FY 17-18 (in Cr)
Cash flow from Operating activities	202.4
Net cash from/(used in) Operating activities	202.4
Cash flow from Investing activities	(283.7)
Net cash from/(used in) Investing activities	(283.7)
Cash flow from Financing activities	70.1
Net cash from/(used) in Financing activities	70.1
Effect of exchange rate changes on cash and cash equivalents	0.0
Net increase /(Decrease) in cash and cash equivalents	(11.2)
Cash and cash equivalents at the beginning of the year	35.9
Cash and cash equivalents at the end of the year	24.6

Detailed Income Statement

FY 16-17 (in Cr)

18.2

(5.3)

For doubtful debts

Expenses other than those related to Insurance Business

4.3

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(4.3)

Profit/(Loss) before tax

2.2

Profit/(Loss) for the year

2.2

Detailed Balance Sheet

FY 16-17 (in Cr)

524.7

652.5

96.9

Current Liabilities

(268.0)

Provisions

(258.5)

Debit Balance In Profit And Loss Account

301.9

Other Net assets

Detailed Cash Flow Statement	FY 16-17 (in Cr)
Cash flow from Operating activities	5,870.6
Net cash from/(used in) Operating activities	5,870.6
Cash flow from Investing activities	2,317.8
Net cash from/(used in) Investing activities	2,317.8
Cash flow from Financing activities	(7,696.0)
Net cash from/(used) in Financing activities	(7,696.0)
Effect of exchange rate changes on cash and cash equivalents	(4.4)
Net increase /(Decrease) in cash and cash equivalents	488.0
Cash and cash equivalents at the beginning of the year	1,222.3
Cash and cash equivalents at the end of the year	1,546.1

Detailed Income Statement

FY 15-16 (in Cr)

9.2

(84.8)

For doubtful debts

Expenses other than those related to Insurance Business

3.3

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(3.3)

Profit/(Loss) before tax

(78.8)

Profit/(Loss) for the year

(78.8)

Detailed Balance Sheet

FY 15-16 (in Cr)

475.1

492.0

81.9

Current Liabilities

(188.9)

Provisions

(214.0)

Debit Balance In Profit And Loss Account

304.0

Other Net assets

Detailed Cash Flow Statement	FY 15-16 (in Cr)
Cash flow from Operating activities	(2,154.0)
Net cash from/(used in) Operating activities	(2,154.0)
Cash flow from Investing activities	514.9
Net cash from/(used in) Investing activities	514.9
Cash flow from Financing activities	1,853.0
Net cash from/(used) in Financing activities	1,853.0
Effect of exchange rate changes on cash and cash equivalents	4.9
Net increase /(Decrease) in cash and cash equivalents	218.8
Cash and cash equivalents at the beginning of the year	1,024.5
Cash and cash equivalents at the end of the year	1,222.3

Detailed Income Statement

FY 14-15 (in Cr)

8.4

(104.7)

For doubtful debts

Expenses other than those related to Insurance Business

2.9

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(2.9)

Profit/(Loss) before tax

(99.3)

0.0

Profit/(Loss) for the year

(99.3)

Detailed Balance Sheet

FY 14-15 (in Cr)

350.0

337.8

61.7

Current Liabilities

(134.2)

Provisions

(140.5)

Debit Balance In Profit And Loss Account

225.2

Other Net assets

Detailed Cash Flow Statement	FY 14-15 (in Cr)
Cash flow from Operating activities	19.8
Net cash from/(used in) Operating activities	19.8
Cash flow from Investing activities	(107.2)
Net cash from/(used in) Investing activities	(107.2)
Cash flow from Financing activities	100.0
Net cash from/(used) in Financing activities	100.0
Effect of exchange rate changes on cash and cash equivalents	0.0
Net increase /(Decrease) in cash and cash equivalents	12.6
Cash and cash equivalents at the beginning of the year	12.9
Cash and cash equivalents at the end of the year	25.5

Detailed Income Statement

FY 13-14 (in Cr)

10.8

(88.1)

For doubtful debts

Expenses other than those related to Insurance Business

2.3

Bad debts written off

Expenses towards CSR activities

Penalties

Towards Excess Expenses of Management

Towards Remuneration Of MD/CEO/WTD/Other KMPs

Foreign Exchange Loss/(Gain

Corporate Social Responsibilty (CSR) Expenses

Sandbox related expenses

Contribution to the Policyholders' Fund towards Excess EoM*

Others

(2.3)

Profit/(Loss) before tax

(79.6)

0.0

Profit/(Loss) for the year

(79.6)

Detailed Balance Sheet

FY 13-14 (in Cr)

250.0

221.3

40.1

Current Liabilities

(72.3)

Provisions

(64.8)

Debit Balance In Profit And Loss Account

125.8

Other Net assets

Detailed Cash Flow Statement	FY 13-14 (in Cr)
Cash flow from Operating activities	(68.4)
Net cash from/(used in) Operating activities	(68.4)
Cash flow from Investing activities	(25.9)
Net cash from/(used in) Investing activities	(25.9)
Cash flow from Financing activities	75.0
Net cash from/(used) in Financing activities	75.0
Effect of exchange rate changes on cash and cash equivalents	(0.0)
Net increase /(Decrease) in cash and cash equivalents	(19.3)
Cash and cash equivalents at the beginning of the year	32.2
Cash and cash equivalents at the end of the year	12.9

Shareholding Pattern

As of Sep 29, 2025 • Careinsurance

Total Shares 1,001.84M

Top Shareholders

Shareholder	Category	Shares (Mn)	% Holding
Religare	Parent Entity	629.41M	62.82%
Other Investors	Other Investors	314.85M	31.43%
Anuj Gulati	Founder	32.40M	3.23%
ESOP Pool Exercised	ESOP Pool	13.48M	1.35%
ESOP Pool Available	ESOP Pool	6.01M	0.60%

#	Shareholder	Category	Shares (Mn)	% Holding
1	Religare	Parent Entity	629.41M	62.82%
2	Other Investors	Other Investors	314.85M	31.43%
3	Anuj Gulati	Founder	32.40M	3.23%
4	ESOP Pool Exercised	ESOP Pool	13.48M	1.35%
5	ESOP Pool Available	ESOP Pool	6.01M	0.60%
6	Trishikar Ventures Llp	Fund	4.33M	0.43%
7	Choosy Impex	Enterprise	0.31M	0.03%
8	Rubamin	Enterprise	0.22M	0.02%
9	Indmax It Sevices	Enterprise	0.15M	0.01%
10	Associated Cansules Pvt Ltd	Fund	0.14M	0.01%
11	Barclays Wealth Trustees India Private Limited	Fund	0.10M	0.01%
12	Sarffin Financial Advisors Private Limited	Fund	0.06M	0.01%
13	Bhaijeeoverseas	Enterprise	0.06M	0.01%
14	Stargate Alphs	Enterprise	0.04M	0.00%
15	Bengal Scarp Processing	Enterprise	0.03M	0.00%
16	Estees Initiatives	Enterprise	0.03M	0.00%
17	Yahooexports	Enterprise	0.03M	0.00%
18	Ranitalinvestments	Enterprise	0.03M	0.00%
19	SSK Exports	Enterprise	0.02M	0.00%
20	Jupiter Estates	Enterprise	0.02M	0.00%
21	Akummercantile	Enterprise	0.02M	0.00%
22	Indo Nippon Foods	Enterprise	0.02M	0.00%
23	Salasar	Enterprise	0.02M	0.00%
24	Astha Foils	Enterprise	0.01M	0.00%
25	titansecurities limited	Enterprise	0.01M	0.00%
26	Accumen	Enterprise	0.01M	0.00%
27	Espiindustriesandchemicals	Enterprise	0.01M	0.00%
28	Chace	Enterprise	0.01M	0.00%
29	Confido Capital Advisors	Enterprise	0.01M	0.00%
30	Naturals Ice cream	Enterprise	0.01M	0.00%
31	Silaris	Enterprise	0.01M	0.00%
32	T Merchandising	Enterprise	0.00M	0.00%
33	Karvy Capital Ltd	Fund	0.00M	0.00%
34	BMW Bird Automotive	Enterprise	0.00M	0.00%
35	Indukantvyapaar	Enterprise	0.00M	0.00%
36	Serai Exports	Enterprise	0.00M	0.00%
37	Arcomfinancial	Enterprise	0.00M	0.00%
38	GWC Financial Services	Enterprise	0.00M	0.00%
39	Smrvainfrastructureprojects	Enterprise	0.00M	0.00%
40	Magnifiq Securities Private Limited	Fund	0.00M	0.00%
41	FE Securities	Enterprise	0.00M	0.00%
42	Aqua Proof Wall Plast	Enterprise	0.00M	0.00%
43	Cleantech Energy Solution	Enterprise	0.00M	0.00%
44	K C Estates	Enterprise	0.00M	0.00%
45	Adarsh Merchants	Enterprise	0.00M	0.00%
46	United Infracore Limited	Enterprise	0.00M	0.00%
47	Bulk Containers	Enterprise	0.00M	0.00%
48	Voloptfinancial	Enterprise	0.00M	0.00%
49	Meghalayatravels	Enterprise	0.00M	0.00%
50	Runit Investments Co Ltd	Fund	0.00M	0.00%
51	Findoc Wealthmart	Enterprise	0.00M	0.00%
52	Moneyedge-IMF	Enterprise	0.00M	0.00%
53	Unlistedkart LLP	Fund	0.00M	0.00%
54	Integrated Fincap	Enterprise	0.00M	0.00%
55	Izuz Consultancy	Enterprise	0.00M	0.00%
56	Deltaagrocommodities	Enterprise	0.00M	0.00%
57	Prudent	Enterprise	0.00M	0.00%
58	Unlisted Live	Enterprise	0.00M	0.00%
59	Future Gems LLP	Enterprise	0.00M	0.00%
60	Vishwas Online	Enterprise	0.00M	0.00%
61	Unlistedstreet Finserv	Enterprise	0.00M	0.00%
62	WWIPL	Enterprise	0.00M	0.00%
63	Puja Trades & Investments	Enterprise	0.00M	0.00%
64	Salasar Fintech	Enterprise	0.00M	0.00%
65	Atum Capital Private Limited	Fund	0.00M	0.00%
66	Prakash Associates	Enterprise	0.00M	0.00%
67	Planify Capital Private Limited	Fund	0.00M	0.00%
68	Swarnim Multi Ventures	Fund	0.00M	0.00%
69	Altius Investech	Fund	0.00M	0.00%
70	Planify Consultancy India Private Limited	Fund	0.00M	0.00%
71	Ranbaxy Holding	Enterprise	0.00M	0.00%
72	Union Bank Of India	Enterprise	0.00M	0.00%
73	Corporation Bank	Enterprise	0.00M	0.00%
74	Gland Celsus Biochemicals	Enterprise	0.00M	0.00%
75	LKP	Enterprise	0.00M	0.00%
	Total		1,001.84M	100%